In conclusion, pathological stage, number of lymph node metastases, concomitant COPD, postoperative plasma D-dimer, and carcinoembryonic antigen were the risk factors for recurrence within 1 year after radical NSCLC. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.